Here four things to know:
1. Mr. Link sold the shares at $44.46 per share.
2. The total value of transaction was $333,450.
3. The 52-week high of the shares is $51.23 and the 52-week low is $31.35.
4. NuVasive received an average rating of “buy” for the short term.
More articles on devices:
NuVasive, Medtronic patent saga continues — 5 key updates
InVivo goes from illiquid to a top-traded stock: 5 key notes
6 key notes on Mazor Robotics’ short interest decline
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
